Skip to main content
main-content

16-02-2017 | Image

Table 2: Clinical efficacy of blinatumomab

*In published report. In reported abstract. Abbreviations: ALL, acute lymphocytic leukaemia; B-NHL, B-cell non-Hodgkin lymphoma; CR, complete response; DLBCL, diffuse large-B-cell lymphoma; FL, follicular lymphoma; i.v., intravenous; MCL, mantle-cell lymphoma; MRD, minimal residual disease; NR, not applicable or available; ORR, overall response rate; PR, partial response; SD, stable disease.

image credits